Linked Life Data

14571820

Source:http://linkedlifedata.com/resource/pubmed/id/14571820

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
53
pubmed:dateCreated
2003-10-23
pubmed:abstractText
A case of a 50-year-old Jehovah's Witness with cryptogenic cirrhosis, severe portal hypertension and a coagulopathy, who underwent splenic embolization to improve the platelet count after receiving recombinant human Factor VIIa, is reported. Following the infusion of recombinant human Factor VIIa, the coagulopathy was rapidly corrected and it became possible to safely embolize her spleen. The changes in prothrombin time, international normalized ratio and activated partial thromboplastin time as well as thrombomodulin, tissue factor and plasminogen activator inhibitor after the infusion are presented. As a result of the splenic embolization, her platelet count normalized and she has been listed for liver transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0172-6390
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1697-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
pubmed:affiliation
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Loyola University Medical Center, Chicago, Stritch School of Medicine, Maywood, IL, USA.
pubmed:publicationType
Journal Article, Case Reports